华兰生物(002007) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥1,837,940,780.64, a decrease of 21.04% compared to the same period last year[3] - The net profit attributable to shareholders for the same period was ¥483,460,736.46, down 10.58% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥454,613,606.58, reflecting a decrease of 10.54% compared to the previous year[3] - The basic earnings per share for Q3 2024 was ¥0.2650, a decline of 10.56% year-on-year[3] - Total operating revenue for Q3 2024 was CNY 3,490,648,261.92, a decrease of 10.8% compared to CNY 3,912,970,763.44 in the same period last year[14] - Net profit attributable to shareholders of the parent company was CNY 923,656,831.05, down 13.5% from CNY 1,067,286,160.09 in Q3 2023[15] - The company reported a gross profit margin of approximately 30.4%, down from 32.5% in the same quarter last year[14] - Basic earnings per share for Q3 2024 were CNY 0.5056, compared to CNY 0.5850 in Q3 2023, indicating a decline of 13.5%[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥16,101,606,403.18, showing a slight decrease of 0.03% from the end of the previous year[3] - The company's total assets amounted to CNY 16,101,606,403.18, slightly down from CNY 16,105,783,295.19 at the end of the previous quarter[13] - Total liabilities decreased to CNY 2,390,509,501.83 from CNY 2,684,600,568.04, reflecting a reduction of approximately 10.9%[15] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 156,695[7] - The largest shareholder, Ankang, holds 17.92% of the shares, totaling 327,787,406 shares[7] - The total equity attributable to shareholders of the parent company was CNY 11,697,012,439.64, reflecting a slight increase from CNY 11,359,430,727.42 at the beginning of the year[13] Cash Flow - Cash flow from operating activities decreased by 33.63% year-on-year, totaling ¥459,709,426.55[3] - The total cash inflow from operating activities was CNY 3,607,081,412.92, compared to CNY 3,560,454,125.64 in the previous period, reflecting a slight increase[16] - The net cash flow from operating activities decreased to CNY 459,709,426.55 from CNY 692,617,559.87 year-on-year[16] - Cash inflow from investment activities surged to CNY 18,045,530,207.37, significantly up from CNY 4,509,215,667.84 in the previous period[16] - The net cash flow from investment activities was CNY 18,539,764.98, a recovery from a negative CNY 547,894,116.69 in the previous year[16] - Cash inflow from financing activities totaled CNY 316,281,000.00, down from CNY 600,000,000.00 in the previous period[17] - The net cash flow from financing activities was negative at CNY -627,795,396.80, compared to CNY -599,154,467.73 in the previous year[17] - The ending balance of cash and cash equivalents was CNY 839,732,455.35, an increase from CNY 642,224,450.63 in the previous period[17] - The company received CNY 17,901,290,166.75 in cash from investment recoveries, a substantial increase from CNY 4,243,424,737.57 in the previous year[16] - The cash paid for purchasing goods and services rose to CNY 1,553,707,874.46 from CNY 1,247,456,232.99 year-on-year[16] Research and Development - The company has ongoing research and development efforts, with development expenditures reported at ¥27,635,945.37, up from ¥26,269,230.64, reflecting an increase of about 5.2%[11] - Research and development expenses for the quarter were CNY 211,913,321.30, a slight decrease from CNY 217,858,152.48 in the previous year[14] Strategic Focus - The company is focusing on market expansion and new product development, although specific figures were not disclosed in the report[11] - The company plans to continue focusing on market expansion and new product development to drive future growth[15] Other Information - The company reported a significant increase in government subsidies, with other income rising by 65.75% year-on-year[6] - The company has not reported any significant mergers or acquisitions during this quarter[11] - The company did not undergo an audit for the third quarter report[17]